Back

Drug-drug interactions of NOACs with comedication: prevalence and implications for adverse events in patients with atrial fibrillation

13 April 2026 (13:30 - 14:05)
Organised by: Logo
Congress Presentation Part of: Stroke prevention in atrial fibrillation Oral Anticoagulation EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Elisa Hennings

University Hospital Basel, Basel (Switzerland)

4 More presentations in this session

Presentation thumbnail
Age-dependent association between heart failure and stroke risk in atrial fibrillation: a nationwide cohort study
Doctor E. Jalli (Pori, FI)
Abstract Slides Video
Presentation thumbnail
Does the effect of anticoagulation on stroke risk differ by CHA2DS2-VA score in patients with atrial fibrillation? A nationwide cohort study.
Mr L. Leppiniemi (Turku, FI)
Abstract Slides Video
Presentation thumbnail
Real-world detection of atrial fibrillation after ischaemic stroke using the FIND-AFDAS meta-machine learning algorithm: an unmet need
Doctor C. Simela (Leeds, GB)
Abstract Slides Video
Presentation thumbnail
Discordance in estimated kidney function by different equations and outcomes in patients with atrial fibrillation on oral anticoagulation: a COMBINE-AF analysis
Assistant Professor P. Krisai (Basel, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Stroke prevention in atrial fibrillation

The Event

Event poster

EHRA 2026

13 April 2026 13:30 CET
You may be interested in
thumbnail
Congress Presentation
Drug interactions in incident NOACs users and risk of bleeding
thumbnail
Congress Presentation
A patient with atrial fibrillation: how to minimise drug-drug interaction?
thumbnail
Congress Session
Evolution of anticoagulation therapy in patients with atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources